Literature DB >> 23774442

Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa.

Karin Meinike Jørgensen1, Tina Wassermann, Peter Østrup Jensen, Wang Hengzuang, Søren Molin, Niels Høiby, Oana Ciofu.   

Abstract

The dynamics of occurrence and the genetic basis of ciprofloxacin resistance were studied in a long-term evolution experiment (940 generations) in wild-type, reference strain (PAO1) and hypermutable (PAOΔmutS and PAOMY-Mgm) P. aeruginosa populations continuously exposed to sub-MICs (1/4) of ciprofloxacin. A rapid occurrence of ciprofloxacin-resistant mutants (MIC of ≥12 μg/ml, representing 100 times the MIC of the original population) were observed in all ciprofloxacin-exposed lineages of PAOΔmutS and PAOMY-Mgm populations after 100 and 170 generations, respectively, and in one of the PAO1 lineages after 240 generations. The genetic basis of resistance was mutations in gyrA (C248T and G259T) and gyrB (C1397A). Cross-resistance to beta-lactam antibiotics was observed in the bacterial populations that evolved during exposure to sublethal concentrations of ciprofloxacin. Our study shows that mutants with high-level ciprofloxacin resistance are selected in P. aeruginosa bacterial populations exposed to sub-MICs of ciprofloxacin. This can have implications for the long-term persistence of resistant bacteria and spread of antibiotic resistance by exposure of commensal bacterial flora to low antibiotic concentrations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23774442      PMCID: PMC3754285          DOI: 10.1128/AAC.00493-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

Review 1.  Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation.

Authors:  Santiago F Elena; Richard E Lenski
Journal:  Nat Rev Genet       Date:  2003-06       Impact factor: 53.242

Review 2.  The role of mutators in the emergence of antibiotic-resistant bacteria.

Authors:  Ian Chopra; Alexander J O'Neill; Keith Miller
Journal:  Drug Resist Updat       Date:  2003-06       Impact factor: 18.500

3.  Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms.

Authors:  Wang Hengzhuang; Hong Wu; Oana Ciofu; Zhijun Song; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

4.  Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  S Jalal; O Ciofu; N Hoiby; N Gotoh; B Wretlind
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

5.  Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment.

Authors:  María D Macià; José L Pérez; Soeren Molin; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

6.  Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.

Authors:  T Akasaka; M Tanaka; A Yamaguchi; K Sato
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

7.  High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

Authors:  A Oliver; R Cantón; P Campo; F Baquero; J Blázquez
Journal:  Science       Date:  2000-05-19       Impact factor: 47.728

8.  Development of antibiotic resistance and up-regulation of the antimutator gene pfpI in mutator Pseudomonas aeruginosa due to inactivation of two DNA oxidative repair genes (mutY, mutM).

Authors:  Lotte Frigaard Mandsberg; Maria D Maciá; Kirsten R Bergmann; Lasse E Christiansen; Morten Alhede; Nikolai Kirkby; Niels Høiby; Antonio Oliver; Oana Ciofu
Journal:  FEMS Microbiol Lett       Date:  2011-09-13       Impact factor: 2.742

9.  Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa.

Authors:  Alex Wong; Nicolas Rodrigue; Rees Kassen
Journal:  PLoS Genet       Date:  2012-09-13       Impact factor: 5.917

10.  Selection of resistant bacteria at very low antibiotic concentrations.

Authors:  Erik Gullberg; Sha Cao; Otto G Berg; Carolina Ilbäck; Linus Sandegren; Diarmaid Hughes; Dan I Andersson
Journal:  PLoS Pathog       Date:  2011-07-21       Impact factor: 6.823

View more
  29 in total

1.  Antimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo Studies.

Authors:  Yucheng Wang; Ximing Wu; Jia Chen; Rehab Amin; Min Lu; Brijesh Bhayana; Jie Zhao; Clinton K Murray; Michael R Hamblin; David C Hooper; Tianhong Dai
Journal:  J Infect Dis       Date:  2016-02-17       Impact factor: 5.226

Review 2.  Biofilm-specific antibiotic tolerance and resistance.

Authors:  I Olsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-29       Impact factor: 3.267

Review 3.  Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.

Authors:  David Lebeaux; Jean-Marc Ghigo; Christophe Beloin
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

4.  Antibiotic treatment enhances the genome-wide mutation rate of target cells.

Authors:  Hongan Long; Samuel F Miller; Chloe Strauss; Chaoxian Zhao; Lei Cheng; Zhiqiang Ye; Katherine Griffin; Ronald Te; Heewook Lee; Chi-Chun Chen; Michael Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-18       Impact factor: 11.205

5.  The evolution of no-cost resistance at sub-MIC concentrations of streptomycin in Streptomyces coelicolor.

Authors:  Sanne Westhoff; Tim Marijn van Leeuwe; Omar Qachach; Zheren Zhang; Gilles Philippus van Wezel; Daniel Eric Rozen
Journal:  ISME J       Date:  2017-01-17       Impact factor: 10.302

6.  De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.

Authors:  Jees Sebastian; Sharmada Swaminath; Rashmi Ravindran Nair; Kishor Jakkala; Atul Pradhan; Parthasarathi Ajitkumar
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

7.  Modeling the Emergence of Antibiotic Resistance in the Environment: an Analytical Solution for the Minimum Selection Concentration.

Authors:  Ben K Greenfield; Shanna Shaked; Carl F Marrs; Patrick Nelson; Ian Raxter; Chuanwu Xi; Thomas E McKone; Olivier Jolliet
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

8.  A large-scale whole-genome comparison shows that experimental evolution in response to antibiotics predicts changes in naturally evolved clinical Pseudomonas aeruginosa.

Authors:  Samuel J T Wardell; Attika Rehman; Lois W Martin; Craig Winstanley; Wayne M Patrick; Iain L Lamont
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

9.  Digital Drug Delivery: On-Off Ultrasound Controlled Antibiotic Release from Coated Matrices with Negligible Background Leaching.

Authors:  Misty L Noble; Pierre D Mourad; Buddy D Ratner
Journal:  Biomater Sci       Date:  2014-06-01       Impact factor: 6.843

10.  Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin.

Authors:  Marwa N Ahmed; Andreas Porse; Morten Otto Alexander Sommer; Niels Høiby; Oana Ciofu
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.